Danaher Co. (NYSE:DHR) Shares Bought by CMH Wealth Management LLC

CMH Wealth Management LLC boosted its position in shares of Danaher Co. (NYSE:DHRGet Rating) by 19.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,340 shares of the conglomerate’s stock after acquiring an additional 5,999 shares during the period. Danaher comprises 3.3% of CMH Wealth Management LLC’s investment portfolio, making the stock its 8th biggest holding. CMH Wealth Management LLC’s holdings in Danaher were worth $9,213,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Norges Bank acquired a new position in Danaher during the 4th quarter worth approximately $2,015,889,000. Castleview Partners LLC acquired a new position in shares of Danaher in the 4th quarter valued at $4,077,000. AustralianSuper Pty Ltd boosted its holdings in shares of Danaher by 916.7% in the 1st quarter. AustralianSuper Pty Ltd now owns 1,168,431 shares of the conglomerate’s stock valued at $342,736,000 after buying an additional 1,053,502 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Danaher by 2.1% in the 1st quarter. Vanguard Group Inc. now owns 51,004,840 shares of the conglomerate’s stock valued at $14,961,250,000 after buying an additional 1,044,650 shares in the last quarter. Finally, Flossbach Von Storch AG boosted its holdings in shares of Danaher by 68.2% in the 1st quarter. Flossbach Von Storch AG now owns 2,453,197 shares of the conglomerate’s stock valued at $719,596,000 after buying an additional 994,835 shares in the last quarter. Institutional investors and hedge funds own 77.27% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. KeyCorp lowered their target price on shares of Danaher from $345.00 to $325.00 and set an “overweight” rating for the company in a report on Friday, July 22nd. Robert W. Baird upped their target price on shares of Danaher from $319.00 to $325.00 in a report on Friday, July 22nd. Benchmark lowered their target price on shares of Danaher from $345.00 to $325.00 and set a “buy” rating for the company in a report on Tuesday. Cowen reduced their price target on shares of Danaher to $340.00 in a research report on Friday, July 22nd. Finally, StockNews.com upgraded shares of Danaher from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 26th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $321.75.

Insider Transactions at Danaher

In other news, CEO Rainer Blair sold 25,000 shares of the company’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $7,500,000.00. Following the transaction, the chief executive officer now directly owns 79,739 shares of the company’s stock, valued at approximately $23,921,700. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, EVP Joakim Weidemanis sold 12,000 shares of the stock in a transaction dated Monday, July 25th. The shares were sold at an average price of $271.13, for a total value of $3,253,560.00. Following the sale, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at approximately $20,171,529.74. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Rainer Blair sold 25,000 shares of the stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $7,500,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,739 shares in the company, valued at $23,921,700. The disclosure for this sale can be found here. Insiders have sold a total of 40,906 shares of company stock valued at $11,823,179 in the last ninety days. 11.20% of the stock is currently owned by company insiders.

Danaher Stock Performance

Danaher stock traded down $3.90 during trading hours on Friday, reaching $262.53. 107,851 shares of the stock were exchanged, compared to its average volume of 2,203,832. The stock has a market cap of $190.98 billion, a P/E ratio of 31.06, a P/E/G ratio of 1.29 and a beta of 0.88. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.75. Danaher Co. has a 52-week low of $233.71 and a 52-week high of $331.68. The firm’s 50 day moving average is $280.99 and its 200 day moving average is $269.91.

Danaher (NYSE:DHRGet Rating) last announced its quarterly earnings data on Thursday, July 21st. The conglomerate reported $2.76 EPS for the quarter, topping analysts’ consensus estimates of $2.35 by $0.41. The company had revenue of $7.75 billion during the quarter, compared to the consensus estimate of $7.29 billion. Danaher had a net margin of 20.61% and a return on equity of 18.57%. Danaher’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.46 EPS. Analysts predict that Danaher Co. will post 10.4 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, September 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.38%. Danaher’s dividend payout ratio (DPR) is presently 11.78%.

Danaher Company Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.